AbbVie Inc (ABBV)
177.95
-1.25
(-0.70%)
USD |
NYSE |
Dec 27, 12:41
AbbVie Research and Development Expense (Annual): 8.453B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Amgen Inc | 4.784B |
Johnson & Johnson | 15.08B |
Eli Lilly and Co | 9.313B |
Merck & Co Inc | 30.53B |
Pfizer Inc | 10.68B |